[HTML][HTML] Wearable devices for physical monitoring of heart: a review

G Prieto-Avalos, NA Cruz-Ramos, G Alor-Hernandez… - Biosensors, 2022 - mdpi.com
Cardiovascular diseases (CVDs) are the leading cause of death globally. An effective
strategy to mitigate the burden of CVDs has been to monitor patients' biomedical variables …

Organelle-level precision with next-generation targeting technologies

A Saminathan, M Zajac, P Anees… - Nature Reviews Materials, 2022 - nature.com
Intracellular organelles are subsystems within a cell, whose activity and chemical
composition reflect the metabolic state of live cells. Alterations in cellular homeostasis …

[HTML][HTML] Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases

Y Liu, Y Huang, C Xu, P An, Y Luo, L Jiao… - International journal of …, 2022 - mdpi.com
High mortality rates due to cardiovascular diseases (CVDs) have attracted worldwide
attention. It has been reported that mitochondrial dysfunction is one of the most important …

[HTML][HTML] Quercetin attenuates cardiac hypertrophy by inhibiting mitochondrial dysfunction through SIRT3/PARP-1 pathway

WJ Chen, Y Cheng, W Li, XK Dong, J Wei… - Frontiers in …, 2021 - frontiersin.org
Cardiac hypertrophy is an important characteristic in the development of hypertensive heart
disease. Mitochondrial dysfunction plays an important role in the pathology of cardiac …

[HTML][HTML] Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases

M Sun, W Jiang, N Mu, Z Zhang, L Yu, H Ma - Journal of Translational …, 2023 - Springer
Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related
death worldwide, and effective therapeutic strategies against CVD are urgently needed …

[HTML][HTML] Pathogenic mitochondrial dysfunction and metabolic abnormalities

WH Moos, DV Faller, IP Glavas, DN Harpp… - Biochemical …, 2021 - Elsevier
Herein we trace links between biochemical pathways, pathogenesis, and metabolic
diseases to set the stage for new therapeutic advances. Cellular and acellular …

Fatty acid metabolism disorders and potential therapeutic traditional Chinese medicines in cardiovascular diseases

X Liu, X Xu, T Zhang, L Xu, H Tao, Y Liu… - Phytotherapy …, 2023 - Wiley Online Library
Cardiovascular diseases are currently the primary cause of mortality in the whole world.
Growing evidence indicated that the disturbances in cardiac fatty acid metabolism are …

[HTML][HTML] mtUPR modulation as a therapeutic target for primary and secondary mitochondrial diseases

P Cilleros-Holgado, D Gómez-Fernández… - International Journal of …, 2023 - mdpi.com
Mitochondrial dysfunction is a key pathological event in many diseases. Its role in energy
production, calcium homeostasis, apoptosis regulation, and reactive oxygen species (ROS) …

The role of mitochondrial dysfunction in preeclampsia: causative factor or collateral damage?

AN Smith, X Wang, DG Thomas… - American journal of …, 2021 - academic.oup.com
Preeclampsia, new onset hypertension in pregnancy, affects~ 5%–10% of the world's
population. Preeclampsia is the leading cause of morbidity and mortality for both the mother …

[HTML][HTML] Impact of air pollution on cardiovascular aging

M Kuntic, I Kuntic, O Hahad, J Lelieveld… - Mechanisms of Ageing …, 2023 - Elsevier
The world population is aging rapidly, and by some estimates, the number of people older
than 60 will double in the next 30 years. With the increase in life expectancy, adverse effects …